Pricing Log in Create free account

Benitec Biopharma Limited (BNTC) vs Fulcrum Therapeutics, Inc. (FULC)

Benitec Biopharma Limited and Fulcrum Therapeutics, Inc. are both Biotechnology companies. Benitec Biopharma Limited and Fulcrum Therapeutics, Inc. are of similar size ($295.1M and $280.0M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against −1.32%. Across the 13 metrics below, Fulcrum Therapeutics, Inc. leads on 8 and Benitec Biopharma Limited on 5.

Valuation

Metric BNTC FULC Biotechnology median
P/E n/m n/m 8.50
P/S 5,034.47 3.37 9.71
P/B 2.13 0.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.43 0.64
EV/Sales 2,636.87 (0.49) 9.21
Earnings yield (12.08%) (33.15%) (33.15%)
Free cash flow yield (4.40%) (23.60%) (25.50%)

Profitability

Metric BNTC FULC Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.21%) (32.38%) (56.36%)
Return on assets (32.28%) (30.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BNTC FULC Biotechnology median
Revenue growth (TTM) (1.32%) 1,939.80% 6.02%
EPS growth (last fiscal year) 6.67% (637.50%) 30.26%
Revenue growth, 5-year CAGR (54.02%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTC FULC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 34.00 31.35 4.72
Net debt to EBITDA 3.52 4.23 0.96

Dividend

Metric BNTC FULC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BNTC FULC Biotechnology median
Market cap 295.08m 280.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack